Does it seem odd that Pharma was able to come up with a vaccination so quickly? It’s almost as if they had already been working on it, no?
Axios News – Pfizer registered $36.8 billion of sales in 2021 from the COVID-19 vaccine it makes with BioNTech.
This vaccine is now officially the top-selling pharmaceutical product ever in a single year, by a huge margin.
- Humira is the next highest, with $20.7 billion reported in 2021 as the next highest in a single year.
Pfizer expects the vaccine will generate $32 billion of sales this year, and the company’s antiviral COVID pill, called Paxlovid, will create $22 billion of revenue.
- Pfizer’s stock dropped more than 5% on those forecasts because Wall Street expected even higher revenue numbers.
About the Author
Hey, c’mon, man – it’s capitalism, and those BIG PHARM dudes have got to eat to.
And have fancy estates in gated communities with security up the ying-yang.
And big yachts in Cape Charles Harbor.
You get a chance like this to capitalize on people’s fears induced in them by your shills in gubmint, you jump on it!
Afterall, who can tell how long it might be before the next financial windfall comes along.
And thanks from a grateful nation for printing these stories to keep us all informed.